Roger Stupp, MD
Enriched profileProfessor, Feinberg School of Medicine · Northwestern University Feinberg School of Medicine
Roger Stupp is Professor, Feinberg School of Medicine at Northwestern University Feinberg School of Medicine. ClinicalTrials.gov lists 16 registered studies with this person as an investigator.
Data verified 26 Oct 2026
Overview
Updated 27 Oct 2026
Roger Stupp, MD, is Professor, Feinberg School of Medicine at Northwestern University Feinberg School of Medicine. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 12 companies, 1 NIH-funded awards (2020–2026).
- Top research focus: Neuro-Oncology / Glioma
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma
Sponsor: Northwestern University
- Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Sponsor: Northwestern University
Industry payments
Updated 26 Oct 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novocure Inc.Program year20258 payments$62,423openpaymentsdata.cms.gov ↗
- Telix PharmaceuticalsProgram year20252 payments
- Ipsen Biopharmaceuticals, IncProgram year20251 payment
NIH funding
Updated 26 Oct 2026
1 NIH research award on record, funded 2020–2026 per NIH RePORTER. The latest:
- Advancing treatment and understanding of immunotherapy in glioblastoma
University of California, San Francisco
FY2026$838,812U19CA264338 - A PHASE 2A TRIAL OF IMMUNE MODULATION IN COMBINATION WITH ULTRASOUND-MEDIATED BLOOD BRAIN BARRIER OPENING IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Northwestern University
FY2026$548,724R01CA245969 - Advancing treatment and understanding of immunotherapy in glioblastoma
University of California, San Francisco
FY2025$838,812U19CA264338
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/roger-stupp-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
onclive.com/authors/roger-stupp-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on recordEditorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chuv.ch ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chuv.ch ↗
- Editorial board member
Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic.oup.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ecancer.org ↗
Secondary affiliations
appointments beyond the home institution- Paul C. Bucy Professor of Neurological Surgery
Northwestern University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chuv.ch ↗ - Professor of Medicine (Hematology/Oncology) and Neurology
Northwestern University Feinberg School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chuv.ch ↗ - Co-Director
Northwestern Medicine Lou & Gene Malnati Brain Tumor Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chuv.ch ↗ - Associate Director for Strategic Initiatives
Robert H. Lurie Comprehensive Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chuv.ch ↗ - Medical staff
Northwestern Memorial Hospital
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University Feinberg School of Medicine
Martin Tallman, MD
Northwestern University Feinberg School of Medicine
Al Benson, MD
Northwestern University Feinberg School of Medicine
Sanjiv Shah, MD
Northwestern University Feinberg School of Medicine
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center